Human Mesenchymal Stem Cells or Mesenchymal Stromal Cells, the “workhorse” of Regenerative Medicine (RegenMed), are a critical starting material in a growing variety of established and emerging RegenMed products. [1],[2] ... More

How hMSCs Could Work in Patients, What Are Their Biomanufacturing Needs, and When Can They Be Safely Stockpiled? On New Year’s Day, 2020, buried in the headlines was news of a ... More

On May 1st, thought leaders from the ISEV and ISCT published online in Cytotherapy a joint statement, “ISEV and ISCT statement on EVs from MSCs and other cells: considerations for potential ... More

Where are we now in our therapeutic response to COVID? As of writing this article, over 1.5 Million Americans have confirmed cases of COVID-19 and 90,000 lives have been lost. ... More

Amid the global search for treatments for COVID-19 related lung disorders, MSCs emerged as one of the promising solutions to treat Acute Respiratory Distress Syndrome (ARDS) [1, 2]. (See our ... More

Patient Safety as First Priority in COVID-19 Treatment The medical and scientific communities are ardently working on promising new treatments for COVID-19. With the urgency to treat patients currently affected ... More

Industry sponsored MSC-based clinical trial activities for COVID-19 As of this writing, more than a dozen companies and groups have announced their interests to develop mesenchymal stromal/stem cell (MSC) based ... More

“If you can’t fly then run, if you can’t run then walk, if you can’t walk then crawl, but whatever you do you have to keep moving forward.” ― Martin ... More

Authored by Mayasari Lim, PhD, Jonathan Carson, PhD, and Jon A. Rowley, PhD, RoosterBio, Inc. Some research suggests that ARDS might be treatable with the secretome of MSCs. Scientists and ... More

With acknowledgement to scientists who sounded the alarm like Dr. Liz Specht and to all health workers on the front lines. What a Successful MSC or MSC-EV Therapy Would Mean ... More